Valletta, Malta, October 9, 2025 -- In 2025, the globally anticipated Web3 event, TOKEN2049 Singapore, will be held with great fanfare. Top projects, investment institutions, and industry leaders from around the world will gather to discuss the convergence of crypto and the real world. Among them, the debut of JoinCare Foundation (JoinCare DAO) became one of the most innovative focuses of this conference.

JoinCare is creating a new paradigm in biomedicine.

JoinCare is a decentralized autonomous organization (DAO) operating based on the JoinCare Protocol, focused on supporting and incubating startups in the biomedicine field. Through Web3 economic models such as RWA (real-world assets), DePIN, and DeSci, JoinCare is building a new value channel for the transformation and commercialization of scientific research results.

The platform focuses on key scientific research areas such as longevity, anti-tumor, and infectious disease prevention and treatment. It is committed to connecting global scientists, entrepreneurs, and Web3 investors to promote biomedical research innovation, make financing more efficient, results more transparent, and value sharing more widely.

Reshaping the logic of scientific research financing with blockchain

JoinCare DAO drives the development of the BIOMED project through the JoinCare Protocol. By integrating AI and RWA technologies, it accelerates the release of value from scientific research results and strives to build a multi-billion dollar biomedical innovation IP matrix.

JoinCare is not only a platform, but also a value hub connecting traditional industries with the Web3 world.

It breaks down traditional financing barriers in an open and collaborative way, making it easier for scientists to obtain funding and resource support, while allowing global community members to participate in scientific research projects with great potential at an early stage and share in future.

Contact Info:
Name: Joincare Bor
Email: Send Email
Organization: Joincare
Website: https://joincare.bio/

Release ID: 89171993

If you encounter any issues, discrepancies, or concerns regarding the content provided in this press release that require attention or if there is a need for a press release takedown, we kindly request that you notify us without delay at error@releasecontact.com (it is important to note that this email is the authorized channel for such matters, sending multiple emails to multiple addresses does not necessarily help expedite your request). Our responsive team will be available round-the-clock to address your concerns within 8 hours and take necessary actions to rectify any identified issues or guide you through the removal process. Ensuring accurate and reliable information is fundamental to our mission.